Velos Pro - Multiple Fragmentation Techniques for Comprehensive QualTechniques for Comprehensive Qual and Confident QuantTim StrattonBay Area LCMS Users Meeting20 Sep 2011
The Velos Pro
C h i S ll M l l St t Id tifi ti• Comprehensive Small Molecule Structure Identification• High scan speed with data dependant acquisition means never having to
know what is present before hand.N bilit t i HCD f t ti h i ith i• New ability to mix HCD fragmentation mechanism with previous mechanisms at ALL MSn levels opens a whole new avenue for structure identification.
• High sensitivity for low level metabolites and impurities – obtainHigh sensitivity for low level metabolites and impurities obtain fragmentation data on previously hard to detect components.
• Confident Small Molecule Quantitation• Easy quantification setup with multiple fragment mechanism options toEasy quantification setup with multiple fragment mechanism options to
achieve a sensitive, selective, and robust method• Employ multiple fragmentation modes in the same run• Post acquisition selection of the best transition to minimize interference q
without reinjection• High dynamic range (5 orders of magnitude) and sensitivity (<50 fg on
column) comparable to triple quad
2 Proprietary & Confidential
The Velos Pro
C h i S ll M l l St t Id tifi ti• Comprehensive Small Molecule Structure Identification• High scan speed with data dependant acquisition means never having to
know what is present before hand.N bilit t i HCD f t ti h i ith i• New ability to mix HCD fragmentation mechanism with previous mechanisms at ALL MSn levels opens a whole new avenue for structure identification.
• High sensitivity for low level metabolites and impurities – obtainHigh sensitivity for low level metabolites and impurities obtain fragmentation data on previously hard to detect components.
• Confident Small Molecule Quantitation• Easy quantification setup with multiple fragment mechanism options toEasy quantification setup with multiple fragment mechanism options to
achieve a sensitive, selective, and robust method• Employ multiple fragmentation modes in the same run• Post acquisition selection of the best transition to minimize interference q
without reinjection• High dynamic range (5 orders of magnitude) and sensitivity (<50 fg on
column) comparable to triple quad
3 Proprietary & Confidential
New Fragmentation Possibilities
Multiple Fragmentation Velos Pro:
Ability to use CID and HCD Techniques
MSn and Fragment Heritage
b y o use C a d C
combinations at multiple
different MSn levels.
LC-MS:Li 10 i di f
Sample:Linear 10 minute gradient of Water:ACN w/ 0.1% Formic.
Hypersil Gold aQ 50X2 1.9µ column
p
Trifluopirazine metabolites from
human liver S9 incubationN Hypersil Gold aQ 50X2 1.9µ column
1.Full scan + CID only MSn2.Full Scan + HCD MS2 + CID MS3
3 F ll S + HCD MS2 + HCD MS3N
NN
F
F F
4 Proprietary & Confidential
3.Full Scan + HCD MS2 + HCD MS3S
F
New Fragmentation Possibilities – HCD vs CIDTrifluopirazine_HCD-HCD #2817 RT: 6.43 AV: 1 NL: 1.95E5 Trifluopirazine_CID-CID #2411 RT: 6.50 AV: 1 NL: 2.07E4T: ITMS + p ESI d w Full ms2 [email protected] [50.00-420.00]
140000
160000
180000
113.1
280.3
T: ITMS + p ESI d w Full ms2 [email protected] [100.00-420.00]
14000
16000
18000
20000141.1Trifluopirazine
HCD MS2
TrifluopirazineCID MS2
40000
60000
80000
100000
120000
Inte
nsity
141.2
70.1
248.398 2 308 3 4000
6000
8000
10000
12000
Inte
nsity
368.3
280 1
50 100 150 200 250 300 350 400m/z
0
20000
40000 98.2 308.3408.4
239.384.1 368.4211.1 348.6184.9
50 100 150 200 250 300 350 400m/z
0
2000
000 280.1 308.2348.3
262.0139.1 408.4340.2230.1210.2147.0
Trifluopirazine_CID-CID #2412 RT: 6.50 AV: 1 NL: 1.47E4T: ITMS + c ESI d w Full ms3 [email protected] [email protected] [50.00-155.00]
113.1
HCD f t ti id
8000
10000
12000
14000
sity
CID MS3
408 141HCD fragmentation provides a broader mass range of fragmentation. CID fragmentation can provide similar fragment detail
2000
4000
6000
8000
Inte
ns
70.298 2
can provide similar fragment detail but may need additional MSn
steps. However, this isn’t always a bad thing…
5 Proprietary & Confidential
50 100 150 200 250 300 350 400m/z
098.2 113.9 146.2
bad thing…
New Fragmentation Possibilities – HCD MSn
Trifluopirazine_HCD-CID #2217 RT: 5.83 AV: 1 NL: 1.86E4T: ITMS + p ESI d w Full ms2 [email protected] [50.00-435.00]“HCDn” allows for p @ [ ]
12000
14000
16000
18000113.0837
296.1679
HCDn allows for even more structure data.
CID can do the same interpretation when going to MS4 (not shown)
4000
6000
8000
10000
Inte
nsity 141.1671
70.0834
264.1678
324 2514
MS . (not shown)MS2 of 424
50 100 150 200 250 300 350 400m/z
0
2000324.2514
424.3353235.0843 364.2516185.0007
264.2 264.1521
10000
12000
14000
16000
18000
nsity 30000
35000
40000
45000
50000
nsity
MS3 HCD-HCD424 296
MS3 HCD-CID424 296NH
•
FF
NN
F F
OHN
N
FOH
2000
4000
6000
8000
10000
Inte
n
235.3296.3
263.5
256.3228 2194 1 297 1121 3 183 0152 95000
10000
15000
20000
25000
Inte
n
296.1775227.2070204 0744139 2329
F
S
NF
F F
S
NF
F F
6 Proprietary & Confidential
50 100 150 200 250 300m/z
0256.3228.2194.1 297.1121.3 183.0152.9
100 150 200 250 300m/z
0227.2070204.0744139.2329
Fragmentation and Metabolite Finding
• Finding the related components remains a challenging step in Metabolite Identification.
• Fragment based techniques are common and useful techniquesM f t id b tt d t ti• More fragments can provide better detection
• HCD fragmentation provides a richer MS2 spectraN
N
N
N
N
NF F
S
NF
F FS
F
N
7 Proprietary & Confidential
N
FISh with HCD Fragmentation
• Parent + Observed MS2 (HCD) Fragments used – 9 total• Able to detect related materials immediately.Able to detect related materials immediately.
8 Proprietary & Confidential
FISh with HCD Fragmentation
N
N
S
NF
F F
MSn Spectral Tree HCD MS2 Fragmentsp HCD MS2 Fragments
9 Proprietary & Confidential
FISh with HCD Fragmentation
-14.097 –CH2N
NH
14.097 CH2
NF
F F
S
10 Proprietary & Confidential
Inclusion of Simple Phase I Modifications
9 HCD Fragments
9 HCD Fragments9 HCD Fragments+ Phase I
11 Proprietary & Confidential
100113.2
HCD CID vs HCD HCD – Mixing Fragment Techniques
60
80
100
Abu
ndan
ce 280.2
141.2
70.1 N
N
N
F F
50 100 150 200 250 300 350 4000
20
40
Rel
ativ
e
70.1
248.298.1 308.2 408.3239.196.2 368.3
S
F
m/z
70
80
90
100
e
248.3
80
90
100248.2
HCD 50% CID 35%
40
50
60
70
elat
ive
Abu
ndan
c
40
50
60
70
ativ
e A
bund
ance
50 100 150 200 2500
10
20
30Re
280.3
247.3 260.3
233.1210.2
0
10
20
30Rel
a
280.2211.2 246.1
12 Proprietary & Confidential
50 100 150 200 250m/z
100 150 200 250m/z
Complementary Fragmentation – CID and HCD
Trifluopirazine_CID-CID #2503 RT: 6.72 AV: 1 NL: 2.44E5T: ITMS + p ESI d w Full ms2 [email protected] [100.00-420.00]
100141.1
Trifluopirazine_HCD-CID #2489 RT: 6.49 AV: 1 NL: 1.19E6T: ITMS + p ESI d w Full ms2 [email protected] [50.00-420.00]
100113.2
N
N
F F
70
80
90
ce
70
80
90
e
280.2
S
NF
F
CID 35%
40
50
60
ativ
e A
bund
anc
40
50
60
ativ
e A
bund
anc
141.2
70.1
HCD 50%CID 35%
20
30
40
Rel
a
368.3
308 2 348 2
20
30
40
Rel
a
248.298.1 308.2
408 3262 2
50 100 150 200 250 300 350 400m/z
0
10 308.2 348.2280.1 369.3262.1139.1 288.2
50 100 150 200 250 300 350 400m/z
0
10408.3262.2
239.196.2 368.3290.2139.156.1
13 Proprietary & Confidential
MSn Fragmentation Heritage
Trifluopirazine_HCD-CID #2489 RT: 6.49 AV: 1 NL: 1.19E6T: ITMS + p ESI d w Full ms2 [email protected] [50.00-420.00]
100113.2
Trifluopirazine_CID-CID #2503 RT: 6.72 AV: 1 NL: 2.44E5T: ITMS + p ESI d w Full ms2 [email protected] [100.00-420.00]
100141.1
N
N
F F
70
80
90
e
280.2
70
80
90
e CID 35%S
NF
F
40
50
60
tive
Abu
ndan
ce
141.2
70.140
50
60
ive
Abu
ndan
ce
HCD 50%CID 35%
20
30
40
Rel
at
70.1
248.298.1 308.2
20
30
40
Rel
at
368.3
50 100 150 200 250 300 350 400m/z
0
10308.2
408.3262.2239.196.2 368.3290.2139.156.1
50 100 150 200 250 300 350 400m/z
0
10 308.2 348.2280.1 369.3262.1139.1 288.2
14 Proprietary & Confidential
m/zm/z
Comprehensive Qual
• HCD and CID• Complementary Fragmentationp y g• More complete fragmentation coverage
• HCD and FISh• HCD and FISh• More fragment coverage = Better search results
• MSn Fragmentation• Fragment heritage aids in identification• Multiple fragment techniques increases linkage information• Multiple fragment techniques increases linkage information
15 Proprietary & Confidential
The Velos Pro
C h i S ll M l l St t Id tifi ti• Comprehensive Small Molecule Structure Identification• High scan speed with data dependant acquisition means never having to
know what is present before hand.N bilit t i HCD f t ti h i ith i• New ability to mix HCD fragmentation mechanism with previous mechanisms at ALL MSn levels opens a whole new avenue for structure identification.
• High sensitivity for low level metabolites and impurities – obtainHigh sensitivity for low level metabolites and impurities obtain fragmentation data on previously hard to detect components.
• Confident Small Molecule Quantitation• Easy quantification setup with multiple fragment mechanism options toEasy quantification setup with multiple fragment mechanism options to
achieve a sensitive, selective, and robust method• Employ multiple fragmentation modes in the same run• Post acquisition selection of the best transition to minimize interference q
without reinjection• High dynamic range (5 orders of magnitude) and sensitivity (<50 fg on
column) comparable to triple quad
16 Proprietary & Confidential
Easy Quantitation Setup – No Prior MRM Tuning
Quantitation with No Tuning. Velos Pro:
High scan rate allows for Post Acquisition Transition
Selection
g sca a e a o s o
simultaneous CID and HCD
fragmentation acquisition.
LC-MS:Sample:Linear 5 minute gradient of Water:MeOH w/ 0.1% Formic.
Hypersil Gold aQ 50X2 1 9µ
p
Rat plasma spiked with
Dextromethorphan and Hypersil Gold aQ 50X2 1.9µ column
Full Scan + CID(258) + HCD(258)
Metabolites. N
O
17 Proprietary & Confidential
Easy Quantitation Setup – No Prior MRM TuningRT: 0.49 - 4.67
4 25 NL:
40
60
80
100at
ive
Abu
ndan
ce4.25
4.23
2.10 3.143 78
NL:9.74E3Base Peak M S M ix3_Std5_01
Mix3_Std5_01 #933 RT: 3.14 AV: 1 NL: 3.34E3T: ITMS + c ESI t E Full ms2 [email protected] [70.00-260.00]
215 1182
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5Time (min)
0
20Rel
a 3.783.122.12 3.67 4.333.26 4.182.43 2.662.05 3.993.081.92 4.422.311.67
1000
1500
2000
2500
3000
Inte
nsity
215.1182
Look at the CID fragmentsSelect m/z 215 and extract
100 150 200 250m/z
0
500 240.1457147.0405104.2404 171.1284
RT: 2.45 - 4.10
100
e
3.14
20
40
60
80
Rel
ativ
e A
bund
ance
3.21 3.883.06 3 382 77
18 Proprietary & Confidential
2.5 3.0 3.5 4.0Time (min)
03 3.883.06 3.382.77
Easy Quantitation Setup – No Prior MRM TuningRT: 0.49 - 4.67
4 25 NL:
40
60
80
100at
ive
Abu
ndan
ce4.25
4.23
2.10 3.143 78
NL:9.74E3Base Peak M S M ix3_Std5_01
Mix3_Std5_01 #934 RT: 3.14 AV: 1 NL: 2.03E2T: ITMS + c ESI t E Full ms2 [email protected] [50.00-260.00]
200147.1111
0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5Time (min)
0
20Rel
a 3.783.122.12 3.67 4.333.26 4.182.43 2.662.05 3.993.081.92 4.422.311.67
50
100
150
200
Inte
nsity
213.2606171.1915
121.1791
Look at the HCD fragmentsSelect m/z 147 and extract
50 100 150 200 250m/z
0
258.383586.2859
RT: 2.45 - 4.10 SM: 7B
100
e
3.14
20
40
60
80R
elat
ive
Abu
ndan
ce
4.013.05 3.673.582 63
19 Proprietary & Confidential
2.5 3.0 3.5 4.0Time (min)
03 582.63
Easy Quantitation Setup – No Prior MRM Tuning
• Selection of CID vs HCD fragments can be performed after acquisition.• Often, one fragmentation technique provides a more intense transition
providing more sensitivity.• Having all the fragments available also allows reselecting fragment ions
to improve selectivity.
RT: 2.45 - 4.10 SM: 7B
90
100
• Reselect, don’t reinject.
m/z 215 m/z 147HCD
RT: 2.45 - 4.10 SM: 7B
1003.13
50
60
70
80
90
e A
bund
ance
CID HCD
50
60
70
80
90
Abu
ndan
ce
Same injectionDiff t l ti
0
10
20
30
40
Rel
ativ
e3.14
10
20
30
40
50
Rel
ativ
e A
3.22 3.80 3.903.462.75 3.532.72 3.00
Different selectionSame Scale
20 Proprietary & Confidential
2.6 2.8 3.0 3.2 3.4 3.6 3.8 4.0Time (min)
0
2.6 2.8 3.0 3.2 3.4 3.6 3.8 4.0Time (min)
0
MSn Quantitation – Ultimate Selectivity in Real Matrix
MSn Quantitation Velos Pro:
Robust MSn fragmentation Ultimate Selectivity
obus S ag e a o
and multiple fragmentation
techniques.
LC-MS:Sample:Linear 5 minute gradient of Water:MeOH w/ 0.1% Formic.
Hypersil Gold aQ 50X2 1 9µ
Human plasma standards with
Dextromethorphan and
Metabolites Hypersil Gold aQ 50X2 1.9µ column
CID (258) CID (210) MS3
Metabolites.N
OH OH
21 Proprietary & Confidential
m/z 201m/z 258
MSn Quantitation – Ultimate Selectivity in Real Matrix
RT: 0.90 - 4.13 SM: 7G
80
1002.65RT: 0.87 - 4.13 SM: 7G
1004.11
MS3 458 201 133MS2 458 201
Std 2
40
60
80
Rel
ativ
e A
bund
ance
40
60
80R
elat
ive
Abu
ndan
ce
4.04
2.653.813.67
3 48
Std 2100 fg/µL5 µL inj.Pl
RT: 0 91 4 09 SM: 7GRT 0 92 4 12 SM 7G
1.0 1.5 2.0 2.5 3.0 3.5 4.0Time (min)
0
20
1.0 1.5 2.0 2.5 3.0 3.5 4.0Time (min)
0
20
R 3.483.15
3.002.432.401.961.710.89Plasma
RT: 0.91 - 4.09 SM: 7G
60
80
100
unda
nce
2.66RT: 0.92 - 4.12 SM: 7G
60
80
100
ndan
ce
4.12
Std 110 fg/µL
0
20
40
Rel
ativ
e A
bu
2.52
3.933.593.422.92
0
20
40
Rel
ativ
e A
bu
4.053.443.39 3.963.31
3.082.972.642.391.971.711.27
10 fg/µL5µL inj.Plasma
22 Proprietary & Confidential
1.0 1.5 2.0 2.5 3.0 3.5 4.0Time (min)
01.0 1.5 2.0 2.5 3.0 3.5 4.0
Time (min)
0
MSn Quantitation – Ultimate Selectivity in Real Matrix
• Without using MS3, detection and quantitation was not possible below 0.1 fg/µL.
• With MS3, quantitation was possible down to 0.01 fg/µL and detection possible below that.
• Triplicate Standard curves were prepared and analyzed, the limit of Quantitation and Detection as well as the relative standard deviation (RSD) are shown below.
Std pg/µL MS2 MS3
1000 8% 5%1000 8% 5%100 5% 4%10 4% 7%1 11% 8%1 11% 8%
0.1 LOQ/LOD, 12% 14%0.01 X LOQ, 10%
23 Proprietary & Confidential
0.005 X LOD
Confident Quantitation
• Multiple Fragment Techniques• More options for detection and development• More options for detection and development
• Full Scan MSn data• Full Scan MS data• Reselect, don’t Reinject
• MSn
• Selectivity• Selectivity
24 Proprietary & Confidential
Acknowledgements
• Robert Mistrik – HighChem• Thermo Fisher Scientific
• Yingying Huang• Rose Herbold• Kate Comstock• Caroline Ding
•All of You•All of You
25 Proprietary & Confidential